Bioventus Inc. financial data

Symbol
BVS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4721 Emperor Boulevard, Suite 100, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % +11%
Quick Ratio 46.2 % +5.94%
Debt-to-equity 365 % +14.2%
Return On Equity -19.4 % +70.4%
Return On Assets -4.99 % +73.3%
Operating Margin -3.39 % +82.7%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 75.4M USD -63.3%
Weighted Average Number of Shares Outstanding, Basic 65.3M shares +3.87%
Weighted Average Number of Shares Outstanding, Diluted 65.3M shares +3.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 555M USD +10.4%
Research and Development Expense 13.7M USD -15.3%
Operating Income (Loss) -18.8M USD +80.9%
Nonoperating Income (Expense) -39M USD +16.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -57.8M USD +60.2%
Income Tax Expense (Benefit) -6.59M USD +34.9%
Net Income (Loss) Attributable to Parent -39.5M USD +78.3%
Earnings Per Share, Basic -0.58 USD/shares +80.3%
Earnings Per Share, Diluted -0.58 USD/shares +80.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.1M USD +60.6%
Accounts Receivable, after Allowance for Credit Loss, Current 122M USD +8%
Inventory, Net 90M USD -7.72%
Assets, Current 299M USD +19.7%
Deferred Income Tax Assets, Net 7.4M USD
Property, Plant and Equipment, Net 27.6M USD +20.3%
Operating Lease, Right-of-Use Asset 9.78M USD -31.6%
Intangible Assets, Net (Excluding Goodwill) 415M USD -15.9%
Goodwill 7.46M USD 0%
Assets 769M USD -5.13%
Accounts Payable, Current 16.8M USD -4.47%
Accrued Liabilities, Current 129M USD +8.24%
Contract with Customer, Liability, Current 2.35M USD -18.9%
Liabilities, Current 211M USD +31.5%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 7.79M USD -32.1%
Other Liabilities, Noncurrent 26.1M USD -15.4%
Liabilities 583M USD -0.34%
Accumulated Other Comprehensive Income (Loss), Net of Tax 445K USD +12.1%
Retained Earnings (Accumulated Deficit) -355M USD -12.5%
Stockholders' Equity Attributable to Parent 149M USD -16.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 187M USD -17.5%
Liabilities and Equity 769M USD -5.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.01M USD -341%
Net Cash Provided by (Used in) Financing Activities -4.24M USD -115%
Net Cash Provided by (Used in) Investing Activities -1M USD +93.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.8M USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 43.1M USD +60.6%
Deferred Tax Assets, Valuation Allowance 46M USD +1714%
Deferred Tax Assets, Gross 46.8M USD +58.6%
Operating Lease, Liability 10.9M USD -29.5%
Payments to Acquire Property, Plant, and Equipment 291K USD -91.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.4M USD +82.5%
Lessee, Operating Lease, Liability, to be Paid 16M USD -22.5%
Property, Plant and Equipment, Gross 58.5M USD +27%
Operating Lease, Liability, Current 3.11M USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.08M USD -12.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.57M USD +1.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.37M USD -35.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.25M USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD -41.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.73M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.62M USD -19.4%
Operating Lease, Payments 1.18M USD +7.09%
Additional Paid in Capital 503M USD +2.16%
Depreciation, Depletion and Amortization 11.8M USD -28.5%
Deferred Tax Assets, Net of Valuation Allowance 840K USD -96.9%
Share-based Payment Arrangement, Expense 2.06M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%